In support of the National Vaccination Program, the Provincial Government of Lanao del Norte, through the Provincial Health Office (PHO), Provincial Social Welfare and Development Office (PSWDO), and Provincial Community Affairs Office (PCAO), went to visit the Municipality of Nunungan on Tuesday, July 6, 2021, for an information drive.
Present during the event to learn more and be enlightened about the vaccination program of the PGLDN were the Barangay Captains, Barangay Kagawads, RHU, and SB Members of the Municipality of Nunungan headed by Municipal Mayor Hon. Marcos Mamay.
Mr. Lyndon G. Calica, the Incident Commander, Provincial Information Officer (PIO), and also head of the Provincial Community Affairs Office, in his opening statement, encouraged the barangay and municipal officials to cut the existing doubts and uncertainty about the safety of the vaccine and get vaccinated to gain protection and also set as good examples to the constituents of Nunungan.
The Provincial Government, headed by Governor Imelda ‘Angging’ Quibranza-Dimaporo, aims to boost the information dissemination campaign on the national vaccination program to increase public confidence in the COVID-19 vaccine and promote the benefits of getting one.
Representatives from the PHO and PSWDO also discussed some updates on the still ongoing inoculation in the different municipalities in the province. Currently, a total of 22,787 1st doses and 9994 2nd doses were administered for A1 to A3 cluster groups, and the inoculation for the A4 has now begun.
Mayor Mamay thanked the Provincial Government for the time and support that is given to his municipality. He also helped urge his constituents to believe in the effectiveness of the vaccine in order for them to gain additional protection from the deadly virus.
Governor Angging sees the need to reach out to communities at the barangay level, particularly those sectors that are wary of getting vaccinated. She also encouraged everyone to only spread factual information rather than false rumors and negativities regarding the COVID-19 vaccine . PIO-LDN